# Copper Peptide Hair Growth Research | GHK-Cu Literature > Copper peptide hair growth in the research: the 45-patient GHK hair-count RCT, the Wnt/anagen mouse study, and what GHK-Cu does to follicles, cited and explained. The strongest controlled signal is a 45-man trial; the mechanism work points to Wnt, VEGF, and anagen induction rather than DHT. Here is what each study actually measured. ## What the copper peptide hair growth evidence establishes Copper peptide hair growth research spans three levels of evidence, and they line up. At the controlled-human level, a 6-month trial of 45 men with androgenetic alopecia found a GHK-containing topical raised hair count significantly over placebo [4]. At the mechanism level, a 2024 mouse study showed a GHK-Cu microemulsion drove follicles into the active growth phase faster than minoxidil [14]. And at the foundational-animal level, copper-peptide complexes stimulated follicle activity in C3H mice as far back as 1991 [7]. GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a copper-binding tripeptide, and the hair work treats it as a follicle signal rather than a hormone blocker. A 2026 review of short peptides for hair loss reports that GHK-Cu raises VEGF in dermal fibroblasts, stimulates microvascular angiogenesis, and promotes follicular extracellular-matrix turnover, citing the 45-patient trial as foundational peptide hair-loss evidence [15]. The proposed mechanism is vascular and structural: more blood supply to the follicle, more matrix support around it, and a longer active growth phase. The follicle-level detail comes from a close analog. AHK-Cu, the alanyl cousin of GHK-Cu, elongated human hair follicles ex vivo and drove dermal-papilla-cell proliferation at 10^-12 to 10^-9 M, and at 10^-9 M it reduced apoptosis — raising the Bcl-2/Bax ratio and lowering cleaved caspase-3 and PARP [8]. That is suggestive for the copper-tripeptide class, but it tests AHK-Cu, not GHK-Cu itself, so it belongs here as analog context rather than direct GHK-Cu efficacy [8]. One caveat travels with all of it: the controlled human trial tested a 5-aminolevulinic-acid-plus-GHK combination (ALAVAX), not pure injectable GHK-Cu, and the mouse work is preclinical [4][14]. There is no standalone human hair trial of pure GHK-Cu. The signal is real and consistent; the framing should stay precise about which form was tested. Compare the skin evidence on [collagen synthesis in fibroblasts](/skin-research). ## Does Copper Peptide Regrow Hair? The controlled human data points to yes, with a combination formulation. In the 6-month ALAVAX trial of 45 men (Norwood-Hamilton II-V), a 5-ALA-plus-GHK topical raised hair count by 52.6 hairs at 100 mg/mL and 71.5 at 50 mg/mL, versus 9.6 for placebo (p<0.05), with no adverse events in any group [4]. The mechanism work reinforces the result. A 2% GHK-Cu ionic-liquid microemulsion activated Wnt/beta-catenin signaling, upregulated VEGF and HGF, and pushed mouse follicles into anagen within 6 days versus 9 for minoxidil, with higher density at 28 days [14]. An AHK-Cu analog (a close copper-tripeptide cousin, not GHK-Cu itself) elongated human hair follicles ex vivo and reduced dermal-papilla-cell apoptosis at 10^-9 M [8]. Taken together, the controlled human result and the preclinical mechanism point the same way, which is why the 2026 short-peptide review treats [the 45-patient hair-count RCT](/hair-research) as foundational [15]. The honest limit: the human evidence is one 45-man trial of a combination product, not pure GHK-Cu, and the rest is preclinical or analog [4][8]. A standalone controlled trial of pure GHK-Cu on hair has not been published, so the right summary is a consistent and promising signal rather than a settled answer. ## Follow-up hair questions These question-level answers sit alongside the full [frequently asked questions about GHK-Cu](/faq) index. ### Do copper peptides stimulate hair growth? Research models report yes: copper-peptide complexes stimulated hair-follicle activity in C3H mice [7], and a 2026 review notes GHK-Cu raises VEGF, drives microvascular angiogenesis, and promotes follicular extracellular-matrix turnover [15]. The strongest controlled human signal is the 45-patient combination-topical trial [4]. ### Does copper peptide regrow hair? In a 6-month trial of 45 men with androgenetic alopecia, a 5-ALA-plus-GHK complex (ALAVAX) raised hair count by 52.6 at 100 mg/mL and 71.5 at 50 mg/mL versus 9.6 for placebo, with no adverse events [4]. That is the foundational controlled result; pure injectable GHK-Cu has no human hair trial of its own. ### Does copper peptide work for hair growth? Controlled human data (the 45-patient ALAVAX RCT) and a 2026 short-peptide review support a hair-growth signal [4][15]. The mechanism is angiogenic and matrix-driven rather than hormonal, but pure GHK-Cu lacks a standalone human hair trial. ### How long does GHK-Cu take to regrow hair? In a mouse model, a 2% GHK-Cu ionic-liquid microemulsion drove follicles into anagen within 6 days versus 9 for minoxidil, with higher density at 28 days [14]; the human ALAVAX trial measured gains over 6 months [4]. Preclinical onset is fast; controlled human results were read across half a year. ### Is copper a DHT blocker? No. The copper-peptide hair mechanism is non-androgenic: the mouse microemulsion study reported no change in testosterone or estradiol, acting via Wnt/beta-catenin, VEGF, and HGF rather than DHT inhibition [14]. It is a follicle and vascular signal, not a hormone blocker. ### How long do copper peptides take to work on hair? Preclinical anagen induction appeared within about a week in the mouse microemulsion study [14], while the controlled human ALAVAX hair-count gains were measured across a 6-month course [4]. The two timeframes describe different evidence levels, not a contradiction. --- A still, careful reading of the GHK-Cu copper-peptide record — each finding set down beside its gap, cited to source, with no clinic in the room and nothing here to sell.